Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Practical recommendations for breathing-adapted radiotherapy].
Simon L, Giraud P, Dumas JL, Marre D, Dupont S, Varmenot N, Ginestet C, Caron J, Marchesi V, Ferreira I, Lorchel F, Garcia R, Rosenwald JC. Simon L, et al. Among authors: marre d. Cancer Radiother. 2007 Jun;11(4):214-24. doi: 10.1016/j.canrad.2007.06.002. Epub 2007 Jul 2. Cancer Radiother. 2007. PMID: 17604206 Review. French.
Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
Laprie A, Catalaa I, Cassol E, McKnight TR, Berchery D, Marre D, Bachaud JM, Berry I, Moyal EC. Laprie A, et al. Among authors: marre d. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):773-81. doi: 10.1016/j.ijrobp.2007.10.039. Int J Radiat Oncol Biol Phys. 2008. PMID: 18262090 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 33518250
[No title available]
[No authors listed] [No authors listed] PMID: 33518244
[No title available]
[No authors listed] [No authors listed] PMID: 33518262
Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study.
Latorzeff I, Bruguière E, Bogart E, Le Deley MC, Lartigau E, Marre D, Pasquier D. Latorzeff I, et al. Among authors: marre d. Front Oncol. 2021 Aug 26;11:701998. doi: 10.3389/fonc.2021.701998. eCollection 2021. Front Oncol. 2021. PMID: 34513681 Free PMC article.
75 results